In diverse types of cancer, including acute myeloid leukaemia, prostate cancer, breast cancer and non-small lung cancer [33–36], (aberrantly) activated CREB has been associated with increased cellular proliferation. This evidence concerns the gene CREB1 and breast carcinoma.